Zobrazeno 1 - 7
of 7
pro vyhledávání: '"P K Flanagan"'
Autor:
Ralley E. Prentice, Rod W. Hunt, Alicia J. Spittle, Michael Ditchfield, Jeff Chen, Megan Burns, Emma K. Flanagan, Emily Wright, Alyson L. Ross, Rimma Goldberg, Sally J. Bell
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 40, Iss , Pp 100827- (2024)
Background: Exposure to maternal inflammation is associated with an increased risk of neurocognitive and developmental disorders in offspring. Early diagnosis and intervention improves childhood motor and cognitive functioning. Neonatal cerebral MRI
Externí odkaz:
https://doaj.org/article/25b228f899994ec6aaf89c1f995f0cbd
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Children with disabilities and their families are at higher risk during emergencies and disasters, which is often attributed to the lack of disability inclusion in emergency response as well as disparities in preparedness. This di
Externí odkaz:
https://doaj.org/article/cf066a4ff4df4761adc4da19def4ba73
Autor:
Jennifer Kelly, Miran Al-Rammahi, Kristian Daly, Paul K. Flanagan, Arun Urs, Marta C. Cohen, Gabriella di Stefano, Marcel J. C. Bijvelds, David N. Sheppard, Hugo R. de Jonge, Ursula E. Seidler, Soraya P. Shirazi-Beechey
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-17 (2022)
Abstract Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Defective CFTR leads to accumulation of dehydrated viscous mucus within the small intestine, luminal acidification and altere
Externí odkaz:
https://doaj.org/article/839c5ac368f2469ea3deaf9f54353d59
Publikováno v:
JGH Open, Vol 5, Iss 1, Pp 28-33 (2021)
Abstract Background and Aim Therapeutic options for inflammatory bowel disease (IBD) have expanded, as has the use of IBD medications in women during the reproductive period. However, no qualitative data exist that examine the pregnancy‐related con
Externí odkaz:
https://doaj.org/article/9438318421a54ee3883bf57e123f075d
Autor:
A. Srivastava, R. Kumari, S. Adhikari, P. Sergeev, J. J. Miettinen, M. H. Suvela, K. Flanagan, A. Slipicevic, N. N. Nupponen, F. Lehmann, C. Heckman
Publikováno v:
HemaSphere, Vol 6, Pp 767-768 (2022)
Externí odkaz:
https://doaj.org/article/f87fe36b5ca7414f8c5b2f9be4bc44bf
Autor:
G G Gebeyehu, G Broglio, E Liu, J K Limdi, C Selinger, J Fiske, V Razsanskaite, P J Smith, P K Flanagan, S Subramanian
Publikováno v:
Journal of Crohn's and Colitis. 17:i723-i724
Background Anti-tumour necrosis factor (anti-TNF) agents are associated with increased infection risk among elderly inflammatory bowel disease (IBD) patients and thus alternative biologics may be preferable. Previous cohort studies have demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a13699cd130f1d884b853c329f289c0e
https://doi.org/10.1093/ecco-jcc/jjac190.0726
https://doi.org/10.1093/ecco-jcc/jjac190.0726
Autor:
F. Noho-Konteh, J. Adetifa, M. Cox, T. Forster, A. Drammeh, J. Njie-Jobe, D. Jeffries, M. Plebanski, P. Ghazal, P. Dickinson, H. Whittle, S. Rowland-Jones, J. Sutherland, K. Flanagan
Publikováno v:
International Journal of Infectious Diseases, Vol 21, Iss S1, p 65 (2014)
Externí odkaz:
https://doaj.org/article/f1f81a2fd9734e498200ecdbf3ebbafd